UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 524

Sortiert nach

The central nervous system effects, pharmacokinetics and safety of the NAALADase‐inhibitor GPI 5693

British journal of clinical pharmacology, 2005-08, Vol.60 (2), p.128-136

2005

Volltextzugriff (PDF)

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers

Clinical pharmacology and therapeutics, 1998-11, Vol.64 (5), p.542-546

1998

Volltextzugriff (PDF)

Establishing risk of human experimentation with drugs: lessons from TGN1412

The Lancet (British edition), 2006-10, Vol.368 (9544), p.1387-1391

2006

Volltextzugriff (PDF)

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

The lancet respiratory medicine, 2013-11, Vol.1 (9), p.714-727

2013

Volltextzugriff (PDF)

Re-engineering the European Union Clinical Trials Directive

The Lancet (British edition), 2012-05, Vol.379 (9828), p.1765-1767

2012

Volltextzugriff (PDF)

Effect of intrapulmonary tetrahydrocannabinol administration in humans

Journal of psychopharmacology (Oxford), 2008-09, Vol.22 (7), p.707-716

2008

Volltextzugriff (PDF)

Undergraduate electives in clinical Pharmacology at the interface of Academia and industry

Clinical therapeutics, 2015-08, Vol.37 (8), p.e96-e97

2015

Volltextzugriff (PDF)

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema

Journal of Allergy and Clinical Immunology, 2005-10, Vol.116 (4), p.876-883

2005

Volltextzugriff (PDF)

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects

Journal of psychopharmacology (Oxford), 2010-11, Vol.24 (11), p.1619-1629

2010

Volltextzugriff (PDF)

Pharmacokinetics and systemic endocrine effects of the phyto‐oestrogen 8‐prenylnaringenin after single oral doses to postmenopausal women

British journal of clinical pharmacology, 2006-09, Vol.62 (3), p.288-296

2006

Volltextzugriff (PDF)

Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE)

Contraception (Stoneham), 2003-09, Vol.68 (3), p.195-202

2003

Volltextzugriff (PDF)

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A 2,3 selective agonist, in comparison with lorazepam in healthy volunteers

Journal of psychopharmacology (Oxford), 2009-08, Vol.23 (6), p.625-632

2009

Volltextzugriff (PDF)

Modelling of the concentration—effect relationship of THC on central nervous system parameters and heart rate — insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

Journal of psychopharmacology (Oxford), 2008-09, Vol.22 (7), p.717-726

2008

Volltextzugriff (PDF)

A novel tumor-specific imaging agent for fluorescence guided surgery: a translational study

Clinical therapeutics, 2015-08, Vol.37 (8), p.e70-e70

2015

Volltextzugriff (PDF)

Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects

British journal of clinical pharmacology, 2005-05, Vol.59 (5), p.495-510

2005

Volltextzugriff (PDF)

The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects

Journal of psychopharmacology (Oxford), 2010-11, Vol.24 (11), p.1671-1679

2010

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response

Clinical pharmacology and therapeutics, 1996-10, Vol.60 (4), p.452-460

1996

Volltextzugriff (PDF)

Cognitive performance and serotonergic function in users of ecstasy

Psychopharmacologia, 2001-01, Vol.153 (2), p.196-202

2001

Volltextzugriff (PDF)

Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625

Journal of psychopharmacology (Oxford), 2010-03, Vol.24 (3), p.363-371

2010

Volltextzugriff (PDF)

Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol

Journal of psychopharmacology (Oxford), 2010-01, Vol.24 (1), p.73-82

2010

Volltextzugriff (PDF)

Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate

Ophthalmology (Rochester, Minn.), 2002-10, Vol.109 (10), p.1887-1891

2002

Volltextzugriff (PDF)

The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol

Journal of psychopharmacology (Oxford), 2012-02, Vol.26 (2), p.292-302

2012

Volltextzugriff (PDF)

The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects

Journal of psychopharmacology (Oxford), 2010-11, Vol.24 (11), p.1681-1687

2010

Volltextzugriff (PDF)

Altered neuroregulation of GH secretion in viscerally obese premenopausal women

The journal of clinical endocrinology and metabolism, 2001-11, Vol.86 (11), p.5509-5515

2001

Volltextzugriff (PDF)

Quantifying Beta‐Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium Labeling

Clinical and translational science, 2016-12, Vol.9 (6), p.321-327

2016

Volltextzugriff (PDF)

1 – 25 von 524

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(485)
Mit Volltextzugriff
(442)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The central nervous system effects, pharmacokinetics and safety of the NAALADase‐inhibitor GPI 5693

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers

Establishing risk of human experimentation with drugs: lessons from TGN1412

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

Re-engineering the European Union Clinical Trials Directive

Effect of intrapulmonary tetrahydrocannabinol administration in humans

Undergraduate electives in clinical Pharmacology at the interface of Academia and industry

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects

Pharmacokinetics and systemic endocrine effects of the phyto‐oestrogen 8‐prenylnaringenin after single oral doses to postmenopausal women

Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE)

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A 2,3 selective agonist, in comparison with lorazepam in healthy volunteers

Modelling of the concentration—effect relationship of THC on central nervous system parameters and heart rate — insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

A novel tumor-specific imaging agent for fluorescence guided surgery: a translational study

Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects

The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects

Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response

Cognitive performance and serotonergic function in users of ecstasy

Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625

Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol

Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate

The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol

The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects

Altered neuroregulation of GH secretion in viscerally obese premenopausal women

Quantifying Beta‐Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium Labeling

Suchergebnisse filtern